News

ViiV Healthcare and the University of North Carolina at Chapel Hill announced a five-year, $20 million renewal of a unique, public-private research partnership solely focused on…
Read More...

AbbVie confirmed the company's activities in the fight to address the COVID-19 public health crisis, including supporting the experimental use of the HIV medicine, Kaletra/Aluvia…
Read More...

CEL-SCI Corporation announces that it is developing an immunotherapy with the potential to treat the COVID-19 coronavirus using its patented LEAPS peptide technology. The LEAPS peptides…
Read More...

NAGASE & CO., LTD. and Osaka University have launched DDS Products Joint Development Research Chair, a course dedicated to research in the development of production methods of…
Read More...

BioCryst Pharmaceuticals, Inc. announced the first patients have been dosed with BCX9930 in a proof of concept trial in paroxysmal nocturnal hemoglobinuria (PNH). These patients were…
Read More...

Urovant Sciences announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application (NDA) for once-daily 75 mg vibegron for the…
Read More...

AMAG Pharmaceuticals, Inc. announced changes to its medical development organization. Effective March 31, 2020, Julie Krop, M.D., Executive Vice President and Chief Medical Officer,…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the Elecsys GALAD score. This algorithmic score combines gender and age…
Read More...

Takeda Pharmaceutical Company Limited will share with members of the United States Congress that it is initiating the development of an anti-SARS-CoV-2 polyclonal hyperimmune globulin…
Read More...

Vir Biotechnology, Inc.and Alnylam Pharmaceuticals, Inc. announced an expansion of their existing collaboration to include the development and commercialization of RNAi therapeutics…
Read More...

Amunix Pharmaceuticals, Inc. announced the successful completion of an oversubscribed $73 million Series A financing. Boston-based Omega Funds led the financing, with participation from…
Read More...

Arcturus Therapeutics and Duke-NUS Medical School (Duke-NUS) announced their partnership to develop a Coronavirus (COVID-19) vaccine for Singapore. The development of a COVID-19 vaccine…
Read More...

Cellectis, a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), and Servier, an international…
Read More...

MIMETAS announces the first product release of her Assay Ready product line: OrganoPlate Caco-2. The product consists of 38 intestinal tubules that are grown under flow conditions…
Read More...

Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider of assay development and advanced laboratory testing is pleased to announce the signing of a…
Read More...

Inovio Pharmaceuticals, Inc. announced an accelerated timeline for developing its DNA vaccine INO-4800 to address COVID-19, the respiratory infection the World Health Organization (WHO)…
Read More...

Heat Biologics, Inc. announced that the Company has formally launched a program within its wholly-owned subsidiary, Zolovax, Inc., to develop a vaccine using its immune activating gp96…
Read More...

ACADIA Pharmaceuticals Inc. and Neuren Pharmaceuticals Limited announced that the U.S. Food and Drug Administration (FDA) granted Rare Pediatric Disease (RPD) designation to trofinetide…
Read More...

MilliporeSigma launched its LANEXO Lab Inventory, Safety and Compliance Management System, a new digital laboratory informatics solution designed to drastically reduce time in labs and…
Read More...

Eli Lilly and Company issued the following statement today regarding the novel coronavirus: Among the concerns raised due to the impact of the novel coronavirus is whether patients…
Read More...